Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Andreone

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Gut|May 19, 2001
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosisA Gramenzi, P Andreone, S Fiorino, et al.
Journal of Hepatology|January 6, 1999
Lamivudine treatment for acute hepatitis B after liver transplantationP Andreone, P Caraceni, G L Grazi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2002
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitisT Stroffolini, P L Almasio, R Di Stefano, et al.
Gut|June 27, 2006
High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?S Berardi, F Lodato, A Gramenzi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 12, 2012
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trialM F Abdelmalek, A Humar, F Stickel, et al.
Journal of Viral Hepatitis|June 1, 2018
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatmentK Agarwal, S H Ahn, M Elkhashab, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Oncology|April 15, 1999
Gross pathologic types of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
Journal of Hepatology|January 6, 1999
Characteristics of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Gut|May 19, 2001
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosisA Gramenzi, P Andreone, S Fiorino, et al.
Journal of Hepatology|January 6, 1999
Lamivudine treatment for acute hepatitis B after liver transplantationP Andreone, P Caraceni, G L Grazi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2002
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitisT Stroffolini, P L Almasio, R Di Stefano, et al.
Gut|June 27, 2006
High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?S Berardi, F Lodato, A Gramenzi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 12, 2012
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trialM F Abdelmalek, A Humar, F Stickel, et al.
Journal of Viral Hepatitis|June 1, 2018
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatmentK Agarwal, S H Ahn, M Elkhashab, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Oncology|April 15, 1999
Gross pathologic types of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
Journal of Hepatology|January 6, 1999
Characteristics of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Pageof 11